FindTrial
Sign In

holmium enuclation of prostate

Holmium Laser Enucleation of the Prostate (HOLEP) versus Bipolar Plasmakinetic Resection System (PKRP) in Treating BPH

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001423
Enrollment
Unknown
Registered
2011-06-26
Start date
2008-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BPH

Interventions

A:PKRP (Bipolar Plasmakinetic Resection System)
B:Holmium Laser Enucleation of the Prostate

Sponsors

Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients aged older than 55 yr and fit for anesthesia; 2. Patients had failed medical therapy with alpha-blockers or 5-alpha reductase inhibitors; 3. International Prostate Symptom Score (IPSS) of 18 or greater and maximum urinary flow rate (Qmax) of less than 15 mL/s, or RU>100ml.

Exclusion criteria

Exclusion criteria: 1. Patients with suspected prostate cancer; 2. Patients with bladder calculus; 3. Patients with Neurogenic bladder; 4. Patients with Previous prostate surgery; 5. Patients with urethral stricture.

Design outcomes

Primary

MeasureTime frame
IPSS;QOL;Qmax;complications;—

Secondary

MeasureTime frame
Operative time and Resected tissue weight;international index of erectile function (IIEF);PVR;hospital stay days and catheterization days;hemoglobin and serum sodiu;—

Contacts

Public ContactZhong Wang
zhongwang2001@yahoo.com+86 21 23271699-5114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026